587 related articles for article (PubMed ID: 30352428)
1. Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
Chen HM; van der Touw W; Wang YS; Kang K; Mai S; Zhang J; Alsina-Beauchamp D; Duty JA; Mungamuri SK; Zhang B; Moran T; Flavell R; Aaronson S; Hu HM; Arase H; Ramanathan S; Flores R; Pan PY; Chen SH
J Clin Invest; 2018 Dec; 128(12):5647-5662. PubMed ID: 30352428
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill
Singh VK; Khan A; Xu Y; Mai S; Zhang L; Mishra A; Restrepo BI; Pan PY; Chen SH; Jagannath C
Front Immunol; 2022; 13():865503. PubMed ID: 35757769
[TBL] [Abstract][Full Text] [Related]
3. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
[TBL] [Abstract][Full Text] [Related]
4. LILRB receptor-mediated regulation of myeloid cell maturation and function.
van der Touw W; Chen HM; Pan PY; Chen SH
Cancer Immunol Immunother; 2017 Aug; 66(8):1079-1087. PubMed ID: 28638976
[TBL] [Abstract][Full Text] [Related]
5. Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.
Chen HM; Sun L; Pan PY; Wang LH; Chen SH
Cancer Immunol Immunother; 2021 Dec; 70(12):3435-3449. PubMed ID: 33877384
[TBL] [Abstract][Full Text] [Related]
6. Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.
Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R
Clin Cancer Res; 2017 Sep; 23(17):5187-5201. PubMed ID: 28698201
[TBL] [Abstract][Full Text] [Related]
7. Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma.
Fan J; Li J; Han J; Zhang Y; Gu A; Song F; Duan J; Yin D; Wang L; Yi Y
Mol Immunol; 2021 Aug; 136():82-97. PubMed ID: 34098344
[TBL] [Abstract][Full Text] [Related]
8. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
9. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
Yang L; Wang B; Qin J; Zhou H; Majumdar APN; Peng F
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):91-97. PubMed ID: 29303012
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors.
Umiker B; Hashambhoy-Ramsay Y; Smith J; Rahman T; Mueller A; Davidson R; Meyer C; Patankar G; Alam MM; Jaffe S; Krukenberg K; Goodman A; Spaulding V; Priess M; Dhaneshwar A; Wong M; Diiorio A; O'Malley K; McGrath L; Willer M; Pepper L; Gostissa M; Kis-Toth K; Wiederschain D; Cohen H; Shaffer DR
Mol Cancer Ther; 2023 Apr; 22(4):471-484. PubMed ID: 36780212
[TBL] [Abstract][Full Text] [Related]
12. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
[TBL] [Abstract][Full Text] [Related]
13. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.
Wiśniewski A; Kowal A; Wyrodek E; Nowak I; Majorczyk E; Wagner M; Pawlak-Adamska E; Jankowska R; Ślesak B; Frydecka I; Kuśnierczyk P
Tissue Antigens; 2015 Jun; 85(6):466-75. PubMed ID: 25855135
[TBL] [Abstract][Full Text] [Related]
15. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.
van der Touw W; Kang K; Luan Y; Ma G; Mai S; Qin L; Bian G; Zhang R; Mungamuri SK; Hu HM; Zhang CC; Aaronson SA; Feldmann M; Yang WC; Chen SH; Pan PY
J Immunol; 2018 Sep; 201(6):1727-1734. PubMed ID: 30068593
[TBL] [Abstract][Full Text] [Related]
17. LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells.
Liang H; Shen X
Biochem Biophys Res Commun; 2020 Jul; 528(2):330-335. PubMed ID: 32448508
[TBL] [Abstract][Full Text] [Related]
18. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
Mami-Chouaib F; Echchakir H; Dorothée G; Vergnon I; Chouaib S
Immunol Rev; 2002 Oct; 188():114-21. PubMed ID: 12445285
[TBL] [Abstract][Full Text] [Related]
19. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
20. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells.
Wu T; Liu W; Guo W; Zhu X
Biomed Pharmacother; 2016 Jul; 81():460-467. PubMed ID: 27261626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
